Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 30, 2014 ) Dallas, TX -- Researcher’s clinical trial report, “Ischemia Reperfusion Injury Global Clinical Trials Review, H2, 2014″ provides data on the Ischemia Reperfusion Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemia Reperfusion Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ischemia Reperfusion Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Researcher’s team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=214296 .
Scope
• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=214296 . (Report Price: Single User License – US$ 2500 and Corporate User License – US$ 7500)
Table of Contents
Table of Contents 2
List of Tables4
List of Figures 5
Introduction 6
Ischemia Reperfusion Injury 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Ischemia Reperfusion Injury to Cardiovascular Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Ischemia Reperfusion Injury to Cardiovascular Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Ischemia Reperfusion Injury 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Ischemia Reperfusion Injury Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Ischemia Reperfusion Injury 32
Jul 01, 2014: Quark Announces Completion of Phase II Trial Evaluating QPI-1002 for Prevention of Delayed Graft Function in Kidney Transplant Patients 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Ikaria Holdings, Inc. 33
Clinical Trial Overview of Ikaria Holdings, Inc. 33
Trophos SA 34
Clinical Trial Overview of Trophos SA 34
Stealth Peptides Inc. 35
Clinical Trial Overview of Stealth Peptides Inc. 35
Prolong Pharmaceuticals 36
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
RnR Market Research
Ritesh Tiwari
+ 1-888-391-5441
sales@rnrmarketresearch.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|